Opioid Use Disorder [OUD]
Conditions
Brief summary
Frequency of negative urine samples (obtained weekly, with missing samples coded as positive) throughout weeks 1-13, supported by Time-Line Follow-Back (TLFB) self-report
Detailed description
Retention in treatment (survival), Opioid craving (OC-VAS; weekly), Opioid withdrawal (Subjective Opioid Withdrawal Scale, SOWS [weekly]), Substance-related problem severity and associated service needs (Addiction Severity Index, validated Swedish Self-report version, ASI-SR]) [monthly], Sleep quality (Pittsburgh Sleep Quality Index: PSQI) [weekly], Insomnia Severity Index (ISI]) [monthly], Level of functioning (WHODAS) [monthly]
Interventions
DRUGdepotlösning
DRUGFilm coated tablets matched to the test product as specified further in uploaded documents
Sponsors
Linkopings Universitet
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of negative urine samples (obtained weekly, with missing samples coded as positive) throughout weeks 1-13, supported by Time-Line Follow-Back (TLFB) self-report | — |
Secondary
| Measure | Time frame |
|---|---|
| Retention in treatment (survival), Opioid craving (OC-VAS; weekly), Opioid withdrawal (Subjective Opioid Withdrawal Scale, SOWS [weekly]), Substance-related problem severity and associated service needs (Addiction Severity Index, validated Swedish Self-report version, ASI-SR]) [monthly], Sleep quality (Pittsburgh Sleep Quality Index: PSQI) [weekly], Insomnia Severity Index (ISI]) [monthly], Level of functioning (WHODAS) [monthly] | — |
Countries
Sweden
Outcome results
None listed